BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chauhan SD, Nilsson H, Ahluwalia A, Hobbs AJ. Release of C-type natriuretic peptide accounts for the biological activity of endothelium-derived hyperpolarizing factor. Proc Natl Acad Sci USA. 2003;100:1426-1431. [PMID: 12552127 DOI: 10.1073/pnas.0336365100] [Cited by in Crossref: 176] [Cited by in F6Publishing: 181] [Article Influence: 8.8] [Reference Citation Analysis]
Number Citing Articles
1 Nakagawa Y, Nishikimi T. CNP, the Third Natriuretic Peptide: Its Biology and Significance to the Cardiovascular System. Biology 2022;11:986. [DOI: 10.3390/biology11070986] [Reference Citation Analysis]
2 Numata G, Takimoto E. Cyclic GMP and PKG Signaling in Heart Failure. Front Pharmacol 2022;13:792798. [DOI: 10.3389/fphar.2022.792798] [Reference Citation Analysis]
3 Perez-Ternero C, Aubdool AA, Makwana R, Sanger GJ, Stimson RH, Chan LF, Moyes AJ, Hobbs AJ. C-type natriuretic peptide is a pivotal regulator of metabolic homeostasis. Proc Natl Acad Sci U S A 2022;119:e2116470119. [PMID: 35333648 DOI: 10.1073/pnas.2116470119] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Smith RJ, Perez-Ternero C, Conole D, Martin C, Myers SH, Hobbs AJ, Selwood DL. A Series of Substituted Bis-Aminotriazines Are Activators of the Natriuretic Peptide Receptor C. J Med Chem 2022. [PMID: 35333039 DOI: 10.1021/acs.jmedchem.1c01974] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Delgado NTB, Rouver WDN, Freitas-Lima LC, Vieira-Alves I, Lemos VS, Dos Santos RL. Sex Differences in the Vasodilation Mediated by G Protein-Coupled Estrogen Receptor (GPER) in Hypertensive Rats. Front Physiol 2021;12:659291. [PMID: 34393807 DOI: 10.3389/fphys.2021.659291] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
6 Moyes AJ, Chu SM, Aubdool AA, Dukinfield MS, Margulies KB, Bedi KC, Hodivala-Dilke K, Baliga RS, Hobbs AJ. C-type natriuretic peptide co-ordinates cardiac structure and function. Eur Heart J 2020;41:1006-20. [PMID: 30903134 DOI: 10.1093/eurheartj/ehz093] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 18.0] [Reference Citation Analysis]
7 Pernomian L, do Prado AF, Silva BR, de Paula TD, Grando MD, Bendhack LM. C-type natriuretic peptide-induced relaxation through cGMP-dependent protein kinase and SERCA activation is impaired in two kidney-one clip rat aorta. Life Sci 2021;272:119223. [PMID: 33610574 DOI: 10.1016/j.lfs.2021.119223] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
8 Preedy MEJ, Baliga RS, Hobbs AJ. Multiplicity of Nitric Oxide and Natriuretic Peptide Signaling in Heart Failure. J Cardiovasc Pharmacol 2020;75:370-84. [PMID: 31498237 DOI: 10.1097/FJC.0000000000000724] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
9 Lerner Y, Hanout W, Ben-Uliel SF, Gani S, Leshem MP, Qvit N. Natriuretic Peptides as the Basis of Peptide Drug Discovery for Cardiovascular Diseases. Curr Top Med Chem 2020;20:2904-21. [PMID: 33050863 DOI: 10.2174/1568026620666201013154326] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
10 Márton Z, Pataricza J, Pollesello P, Varró A, Papp JG. The Novel Inodilator ORM-3819 Relaxes Isolated Porcine Coronary Arteries: Role of Voltage-Gated Potassium Channel Activation. J Cardiovasc Pharmacol 2019;74:218-24. [PMID: 31356552 DOI: 10.1097/FJC.0000000000000700] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
11 Pons S, Arnaud M, Loiselle M, Arrii E, Azoulay E, Zafrani L. Immune Consequences of Endothelial Cells' Activation and Dysfunction During Sepsis. Crit Care Clin 2020;36:401-13. [PMID: 32172821 DOI: 10.1016/j.ccc.2019.12.001] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 7.7] [Reference Citation Analysis]
12 Kränkel N, van Craenenbroeck E, Adams V. Exercise and Vascular Function. Textbook of Sports and Exercise Cardiology 2020. [DOI: 10.1007/978-3-030-35374-2_40] [Reference Citation Analysis]
13 de Roij van Zuijdewijn CLM, van Gastel LHA, Ter Wee PM, Bots ML, Blankestijn PJ, van den Dorpel MA, Fouque D, Nubé MJ, Grooteman MPC. The effect of natriuretic C-type peptide and its change over time on mortality in patients on haemodialysis or haemodiafiltration. Clin Kidney J 2021;14:375-81. [PMID: 33564441 DOI: 10.1093/ckj/sfz156] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
14 Breinholt VM, Rasmussen CE, Mygind PH, Kjelgaard-Hansen M, Faltinger F, Bernhard A, Zettler J, Hersel U. TransCon CNP, a Sustained-Release C-Type Natriuretic Peptide Prodrug, a Potentially Safe and Efficacious New Therapeutic Modality for the Treatment of Comorbidities Associated with Fibroblast Growth Factor Receptor 3-Related Skeletal Dysplasias. J Pharmacol Exp Ther 2019;370:459-71. [PMID: 31235532 DOI: 10.1124/jpet.119.258251] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 8.5] [Reference Citation Analysis]
15 Moyes AJ, Hobbs AJ. C-type Natriuretic Peptide: A Multifaceted Paracrine Regulator in the Heart and Vasculature. Int J Mol Sci 2019;20:E2281. [PMID: 31072047 DOI: 10.3390/ijms20092281] [Cited by in Crossref: 66] [Cited by in F6Publishing: 70] [Article Influence: 16.5] [Reference Citation Analysis]
16 Chen C, Guo C, Gao J, Shi K, Cheng J, Zhang J, Chen S, Liu Y, Liu A. Vasorelaxant and antihypertensive effects of Tianshu Capsule on rats: An in vitro and in vivo approach. Biomedicine & Pharmacotherapy 2019;111:188-97. [DOI: 10.1016/j.biopha.2018.12.061] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
17 Ren M, Ng FL, Warren HR, Witkowska K, Baron M, Jia Z, Cabrera C, Zhang R, Mifsud B, Munroe PB, Xiao Q, Townsend-Nicholson A, Hobbs AJ, Ye S, Caulfield MJ. The biological impact of blood pressure-associated genetic variants in the natriuretic peptide receptor C gene on human vascular smooth muscle. Hum Mol Genet 2018;27:199-210. [PMID: 29040610 DOI: 10.1093/hmg/ddx375] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
18 Malek M. Brain consequences of acute kidney injury: Focusing on the hippocampus. Kidney Res Clin Pract 2018;37:315-22. [PMID: 30619687 DOI: 10.23876/j.krcp.18.0056] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 4.2] [Reference Citation Analysis]
19 Conole D, Myers SH, Mota F, Hobbs AJ, Selwood DL. Biophysical screening methods for extracellular domain peptide receptors, application to natriuretic peptide receptor C ligands. Chem Biol Drug Des 2019;93:1011-20. [PMID: 30218492 DOI: 10.1111/cbdd.13395] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
20 Day A, Jameson Z, Hyde C, Simbi B, Fowkes R, Lawson C. C-Type Natriuretic Peptide (CNP) Inhibition of Interferon-γ-Mediated Gene Expression in Human Endothelial Cells In Vitro. Biosensors (Basel) 2018;8:E86. [PMID: 30223437 DOI: 10.3390/bios8030086] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
21 Bie P. Natriuretic Peptides and Normal Body Fluid Regulation. Compr Physiol 2018;8:1211-49. [PMID: 29978892 DOI: 10.1002/cphy.c180002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 4.4] [Reference Citation Analysis]
22 Molica F, Figueroa XF, Kwak BR, Isakson BE, Gibbins JM. Connexins and Pannexins in Vascular Function and Disease. Int J Mol Sci 2018;19:E1663. [PMID: 29874791 DOI: 10.3390/ijms19061663] [Cited by in Crossref: 26] [Cited by in F6Publishing: 31] [Article Influence: 5.2] [Reference Citation Analysis]
23 Goto K, Ohtsubo T, Kitazono T. Endothelium-Dependent Hyperpolarization (EDH) in Hypertension: The Role of Endothelial Ion Channels. Int J Mol Sci 2018;19:E315. [PMID: 29361737 DOI: 10.3390/ijms19010315] [Cited by in Crossref: 40] [Cited by in F6Publishing: 44] [Article Influence: 8.0] [Reference Citation Analysis]
24 Vittorio TJ. Quit Smoking, Close Your Mouth, Drop the Fork and Get off the Couch. AOWMC 2017;7. [DOI: 10.15406/aowmc.2017.07.00208] [Reference Citation Analysis]
25 Khaddaj Mallat R, Mathew John C, Kendrick DJ, Braun AP. The vascular endothelium: A regulator of arterial tone and interface for the immune system. Crit Rev Clin Lab Sci 2017;54:458-70. [PMID: 29084470 DOI: 10.1080/10408363.2017.1394267] [Cited by in Crossref: 67] [Cited by in F6Publishing: 58] [Article Influence: 11.2] [Reference Citation Analysis]
26 Seki T, Goto K, Kansui Y, Ohtsubo T, Matsumura K, Kitazono T. Angiotensin II Receptor-Neprilysin Inhibitor Sacubitril/Valsartan Improves Endothelial Dysfunction in Spontaneously Hypertensive Rats. J Am Heart Assoc 2017;6:e006617. [PMID: 29042424 DOI: 10.1161/JAHA.117.006617] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 3.5] [Reference Citation Analysis]
27 Nielsen PM, Grimm D, Wehland M, Simonsen U, Krüger M. The Combination of Valsartan and Sacubitril in the Treatment of Hypertension and Heart Failure - an Update. Basic Clin Pharmacol Toxicol 2018;122:9-18. [DOI: 10.1111/bcpt.12912] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
28 Yuzugulen J, Douthwaite JA, Wood EG, Villar IC, Patel NSA, Jegard J, Gaertner H, Rossitto-Borlat I, Rose K, Hartley O, Cutillas PR, Ahluwalia A, Corder R. Characterisation of preproendothelin-1 derived peptides identifies Endothelin-Like Domain Peptide as a modulator of Endothelin-1. Sci Rep 2017;7:4956. [PMID: 28694457 DOI: 10.1038/s41598-017-05365-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
29 Greven J, Pfeifer R, Zhi Q, Pape HC. Update on the role of endothelial cells in trauma. Eur J Trauma Emerg Surg 2018;44:667-77. [PMID: 28674817 DOI: 10.1007/s00068-017-0812-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
30 Tykocki NR, Boerman EM, Jackson WF. Smooth Muscle Ion Channels and Regulation of Vascular Tone in Resistance Arteries and Arterioles. Compr Physiol 2017;7:485-581. [PMID: 28333380 DOI: 10.1002/cphy.c160011] [Cited by in Crossref: 160] [Cited by in F6Publishing: 170] [Article Influence: 26.7] [Reference Citation Analysis]
31 Chuaiphichai S, Crabtree MJ, Mcneill E, Hale AB, Trelfa L, Channon KM, Douglas G. A key role for tetrahydrobiopterin-dependent endothelial NOS regulation in resistance arteries: studies in endothelial cell tetrahydrobiopterin-deficient mice. Br J Pharmacol 2017;174:657-71. [PMID: 28128438 DOI: 10.1111/bph.13728] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 4.3] [Reference Citation Analysis]
32 Patel H, Alkhawam H, Madanieh R, Shah N, Kosmas CE, Vittorio TJ. Aerobic vs anaerobic exercise training effects on the cardiovascular system. World J Cardiol 2017; 9(2): 134-138 [PMID: 28289526 DOI: 10.4330/wjc.v9.i2.134] [Cited by in Crossref: 88] [Cited by in F6Publishing: 88] [Article Influence: 14.7] [Reference Citation Analysis]
33 Khirmanov VN. The role of natriuretic peptides in regulation of cardiovascular system. Kardiol serdechno-sosud khir 2017;10:3. [DOI: 10.17116/kardio201710123-25] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
34 Leung SW, Vanhoutte PM. Endothelium-dependent hyperpolarization: age, gender and blood pressure, do they matter? Acta Physiol (Oxf) 2017;219:108-23. [PMID: 26548576 DOI: 10.1111/apha.12628] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 6.7] [Reference Citation Analysis]
35 Caniffi C, Cerniello FM, Gobetto MN, Sueiro ML, Costa MA, Arranz C. Vascular Tone Regulation Induced by C-Type Natriuretic Peptide: Differences in Endothelium-Dependent and -Independent Mechanisms Involved in Normotensive and Spontaneously Hypertensive Rats. PLoS One 2016;11:e0167817. [PMID: 27936197 DOI: 10.1371/journal.pone.0167817] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
36 Ellinsworth DC, Sandow SL, Shukla N, Liu Y, Jeremy JY, Gutterman DD. Endothelium-Derived Hyperpolarization and Coronary Vasodilation: Diverse and Integrated Roles of Epoxyeicosatrienoic Acids, Hydrogen Peroxide, and Gap Junctions. Microcirculation 2016;23:15-32. [PMID: 26541094 DOI: 10.1111/micc.12255] [Cited by in Crossref: 44] [Cited by in F6Publishing: 47] [Article Influence: 6.3] [Reference Citation Analysis]
37 Zayed MA, Harring SD, Abendschein DR, Vemuri C, Lu D, Detering L, Liu Y, Woodard PK. Natriuretic Peptide Receptor-C is Up-Regulated in the Intima of Advanced Carotid Artery Atherosclerosis. J Med Surg Pathol 2016;1:131. [PMID: 27547837 DOI: 10.4172/2472-4971.1000131] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
38 Pernomian L, Prado AF, Silva BR, Azevedo A, Pinheiro LC, Tanus-Santos JE, Bendhack LM. C-Type Natriuretic Peptide Induces Anti-contractile Effect Dependent on Nitric Oxide, Oxidative Stress, and NPR-B Activation in Sepsis. Front Physiol 2016;7:226. [PMID: 27445832 DOI: 10.3389/fphys.2016.00226] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
39 Hu P, Xia X, Xuan Q, Huang BY, Liu SY, Zhang DD, Jiang GM, Xu Y, Qin YH. Neutral endopeptidase and natriuretic peptide receptors participate in the regulation of C-type natriuretic peptide expression in renal interstitial fibrosis. Journal of Receptors and Signal Transduction 2017;37:71-83. [DOI: 10.3109/10799893.2016.1155068] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
40 Emani S, Meyer M, Palm D, Holzmeister J, Haas GJ. Ularitide: a natriuretic peptide candidate for the treatment of acutely decompensated heart failure. Future Cardiol 2015;11:531-46. [PMID: 26278236 DOI: 10.2217/fca.15.53] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
41 Umaru B, Pyriochou A, Kotsikoris V, Papapetropoulos A, Topouzis S. ATP-sensitive potassium channel activation induces angiogenesis in vitro and in vivo. J Pharmacol Exp Ther 2015;354:79-87. [PMID: 25977483 DOI: 10.1124/jpet.114.222000] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
42 Sangaralingham SJ, McKie PM, Ichiki T, Scott CG, Heublein DM, Chen HH, Bailey KR, Redfield MM, Rodeheffer RJ, Burnett JC Jr. Circulating C-type natriuretic peptide and its relationship to cardiovascular disease in the general population. Hypertension 2015;65:1187-94. [PMID: 25895587 DOI: 10.1161/HYPERTENSIONAHA.115.05366] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 3.4] [Reference Citation Analysis]
43 Cabiati M, Burchielli S, Matteucci M, Svezia B, Panchetti L, Caselli C, Prescimone T, Morales M, Del Ry S. Dipyridamole-induced C-type natriuretic peptide mRNA overexpression in a minipig model of pacing-induced left ventricular dysfunction. Peptides 2015;64:67-73. [DOI: 10.1016/j.peptides.2015.01.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
44 Stott JB, Barrese V, Jepps TA, Leighton EV, Greenwood IA. Contribution of Kv7 channels to natriuretic peptide mediated vasodilation in normal and hypertensive rats. Hypertension 2015;65:676-82. [PMID: 25547342 DOI: 10.1161/HYPERTENSIONAHA.114.04373] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 4.8] [Reference Citation Analysis]
45 Hu P, Zhang XC, Kong HB, Xia X, Hu B, Qin YH. Exogenous C-type natriuretic peptide infusion ameliorates unilateral ureteral obstruction-induced tubulointerstitial fibrosis in rats. Lab Invest 2015;95:263-72. [PMID: 25437644 DOI: 10.1038/labinvest.2014.149] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
46 Moyes AJ, Khambata RS, Villar I, Bubb KJ, Baliga RS, Lumsden NG, Xiao F, Gane PJ, Rebstock AS, Worthington RJ, Simone MI, Mota F, Rivilla F, Vallejo S, Peiró C, Sánchez Ferrer CF, Djordjevic S, Caulfield MJ, MacAllister RJ, Selwood DL, Ahluwalia A, Hobbs AJ. Endothelial C-type natriuretic peptide maintains vascular homeostasis. J Clin Invest 2014;124:4039-51. [PMID: 25105365 DOI: 10.1172/JCI74281] [Cited by in Crossref: 104] [Cited by in F6Publishing: 108] [Article Influence: 11.6] [Reference Citation Analysis]
47 Chen G, Zhao J, Yin Y, Wang B, Liu Q, Li P, Zhao L, Zhou H. C-type natriuretic peptide attenuates LPS-induced endothelial activation: involvement of p38, Akt, and NF-κB pathways. Amino Acids 2014;46:2653-63. [DOI: 10.1007/s00726-014-1816-x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
48 Peake NJ, Hobbs AJ, Pingguan-Murphy B, Salter DM, Berenbaum F, Chowdhury TT. Role of C-type natriuretic peptide signalling in maintaining cartilage and bone function. Osteoarthritis Cartilage 2014;22:1800-7. [PMID: 25086404 DOI: 10.1016/j.joca.2014.07.018] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 3.9] [Reference Citation Analysis]
49 Demirtas S, Karahan O, Yazici S, Guclu O, Caliskan A, Tezcan O, Yavuz C. Diagnostic value of plasma C-type natriuretic peptide levels in determination of the duration of mesenteric ischaemia. Cardiovasc J Afr 2014;25:200-3. [PMID: 24967686 DOI: 10.5830/CVJA-2014-033] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
50 Han J, He GW, Chen ZW. Protective Effect and Mechanism of Total Flavones from Rhododendron simsii Planch on Endothelium-Dependent Dilatation and Hyperpolarization in Cerebral Ischemia-Reperfusion and Correlation to Hydrogen Sulphide Release in Rats. Evid Based Complement Alternat Med 2014;2014:904019. [PMID: 25050128 DOI: 10.1155/2014/904019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
51 Guo S, Barringer F, Zois NE, Goetze JP, Ashina M. Natriuretic peptides and cerebral hemodynamics. Regulatory Peptides 2014;192-193:15-23. [DOI: 10.1016/j.regpep.2014.07.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
52 Akseki Temür H, Vardar SA, Demir M, Palabıyık O, Karaca A, Guksu Z, Ortanca A, Süt N. The alteration of NTproCNP plasma levels following anaerobic exercise in physically active young men. Anatol J Cardiol 2015;15:97-102. [PMID: 25252292 DOI: 10.5152/akd.2014.5204] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
53 Bice JS, Burley DS, Baxter GF. Novel approaches and opportunities for cardioprotective signaling through 3',5'-cyclic guanosine monophosphate manipulation. J Cardiovasc Pharmacol Ther 2014;19:269-82. [PMID: 24572031 DOI: 10.1177/1074248413518971] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
54 Burley DS, Cox CD, Zhang J, Wann KT, Baxter GF. Natriuretic peptides modulate ATP-sensitive K(+) channels in rat ventricular cardiomyocytes. Basic Res Cardiol 2014;109:402. [PMID: 24477916 DOI: 10.1007/s00395-014-0402-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
55 Pereira NL, Redfield MM, Scott C, Tosakulwong N, Olson TM, Bailey KR, Rodeheffer RJ, Burnett JC Jr. A functional genetic variant (N521D) in natriuretic peptide receptor 3 is associated with diastolic dysfunction: the prevalence of asymptomatic ventricular dysfunction study. PLoS One 2014;9:e85708. [PMID: 24465655 DOI: 10.1371/journal.pone.0085708] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
56 Novodvorsky P, Chico TJ. The Role of the Transcription Factor KLF2 in Vascular Development and Disease. Genetics of Cardiovascular Disease. Elsevier; 2014. pp. 155-88. [DOI: 10.1016/b978-0-12-386930-2.00007-0] [Cited by in Crossref: 67] [Cited by in F6Publishing: 71] [Article Influence: 7.4] [Reference Citation Analysis]
57 Hobbs AJ. Natriuretic peptide receptors and heart failure: to B or not to B blocked? Naunyn-Schmiedeberg's Arch Pharmacol 2014;387:1-4. [DOI: 10.1007/s00210-013-0946-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
58 Del Ry S, Cabiati M, Clerico A. Recent advances on natriuretic peptide system: New promising therapeutic targets for the treatment of heart failure. Pharmacological Research 2013;76:190-8. [DOI: 10.1016/j.phrs.2013.08.006] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
59 Sullivan MN, Earley S. TRP channel Ca(2+) sparklets: fundamental signals underlying endothelium-dependent hyperpolarization. Am J Physiol Cell Physiol 2013;305:C999-C1008. [PMID: 24025865 DOI: 10.1152/ajpcell.00273.2013] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 4.7] [Reference Citation Analysis]
60 Campbell WB, Gauthier KM. Inducible endothelium-derived hyperpolarizing factor: role of the 15-lipoxygenase-EDHF pathway. J Cardiovasc Pharmacol 2013;61:176-87. [PMID: 23249676 DOI: 10.1097/FJC.0b013e31828165db] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
61 von Lueder TG, Sangaralingham SJ, Wang BH, Kompa AR, Atar D, Burnett JC Jr, Krum H. Renin-angiotensin blockade combined with natriuretic peptide system augmentation: novel therapeutic concepts to combat heart failure. Circ Heart Fail 2013;6:594-605. [PMID: 23694773 DOI: 10.1161/CIRCHEARTFAILURE.112.000289] [Cited by in Crossref: 95] [Cited by in F6Publishing: 102] [Article Influence: 9.5] [Reference Citation Analysis]
62 Kriska T, Cepura C, Siangjong L, Wan TC, Auchampach JA, Shaish A, Haratz D, Kumar G, Falck JR, Gauthier KM, Campbell WB. Effect of human 15-lipoxygenase-1 metabolites on vascular function in mouse mesenteric arteries and hearts. Prostaglandins Other Lipid Mediat 2013;106:8-15. [PMID: 23872364 DOI: 10.1016/j.prostaglandins.2013.07.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
63 Zamani P, Greenberg BH. Novel vasodilators in heart failure. Curr Heart Fail Rep 2013;10:1-11. [PMID: 23299783 DOI: 10.1007/s11897-012-0126-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
64 Ellinsworth DC, Earley S, Murphy TV, Sandow SL. Endothelial control of vasodilation: integration of myoendothelial microdomain signalling and modulation by epoxyeicosatrienoic acids. Pflugers Arch 2014;466:389-405. [PMID: 23748495 DOI: 10.1007/s00424-013-1303-3] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 3.2] [Reference Citation Analysis]
65 Erbas D. Physiological Importance of Endothelium. Endothelium 2013. [DOI: 10.1201/b14907-2] [Reference Citation Analysis]
66 Tang G, Yang G, Jiang B, Ju Y, Wu L, Wang R. H₂S is an endothelium-derived hyperpolarizing factor. Antioxid Redox Signal 2013;19:1634-46. [PMID: 23418650 DOI: 10.1089/ars.2012.4805] [Cited by in Crossref: 100] [Cited by in F6Publishing: 105] [Article Influence: 10.0] [Reference Citation Analysis]
67 Király I, Pataricza J, Bajory Z, Simonsen U, Varro A, Papp JG, Pajor L, Kun A. Involvement of large-conductance Ca(2+) -activated K(+) channels in both nitric oxide and endothelium-derived hyperpolarization-type relaxation in human penile small arteries. Basic Clin Pharmacol Toxicol 2013;113:19-24. [PMID: 23414060 DOI: 10.1111/bcpt.12059] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
68 Borgognone A, Lowe KL, Watson SP, Madhani M. Natriuretic peptides induce weak VASP phosphorylation at Serine 239 in platelets. Platelets 2014;25:1-7. [PMID: 23469931 DOI: 10.3109/09537104.2013.773969] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
69 Del Ry S. C-type natriuretic peptide: A new cardiac mediator. Peptides 2013;40:93-8. [DOI: 10.1016/j.peptides.2012.12.010] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 3.6] [Reference Citation Analysis]
70 Boedtkjer E, Kim S, Aalkjaer C. Endothelial alkalinisation inhibits gap junction communication and endothelium-derived hyperpolarisations in mouse mesenteric arteries. J Physiol 2013;591:1447-61. [PMID: 23297309 DOI: 10.1113/jphysiol.2012.247478] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
71 Vesely DL. Natriuretic Hormones. Seldin and Giebisch's The Kidney 2013. [DOI: 10.1016/b978-0-12-381462-3.00037-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
72 Baliga RS, Macallister RJ, Hobbs AJ. Vasoactive Peptides and the Pathogenesis of Pulmonary Hypertension: Role and Potential Therapeutic Application. Handbook of Experimental Pharmacology 2013. [DOI: 10.1007/978-3-662-45805-1_19] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
73 Barton M, Baretella O, Meyer MR. Obesity and risk of vascular disease: importance of endothelium-dependent vasoconstriction. Br J Pharmacol 2012;165:591-602. [PMID: 21557734 DOI: 10.1111/j.1476-5381.2011.01472.x] [Cited by in Crossref: 74] [Cited by in F6Publishing: 77] [Article Influence: 6.7] [Reference Citation Analysis]
74 Kriska T, Cepura C, Magier D, Siangjong L, Gauthier KM, Campbell WB. Mice lacking macrophage 12/15-lipoxygenase are resistant to experimental hypertension. Am J Physiol Heart Circ Physiol 2012;302:H2428-38. [PMID: 22467300 DOI: 10.1152/ajpheart.01120.2011] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 2.9] [Reference Citation Analysis]
75 Capra V, Bäck M, Barbieri SS, Camera M, Tremoli E, Rovati GE. Eicosanoids and Their Drugs in Cardiovascular Diseases: Focus on Atherosclerosis and Stroke: EICOSANOIDS AND THEIR DRUGS IN CVDS. Med Res Rev 2013;33:364-438. [DOI: 10.1002/med.21251] [Cited by in Crossref: 75] [Cited by in F6Publishing: 81] [Article Influence: 6.8] [Reference Citation Analysis]
76 Khambata RS, Panayiotou CM, Hobbs AJ. Natriuretic peptide receptor-3 underpins the disparate regulation of endothelial and vascular smooth muscle cell proliferation by C-type natriuretic peptide. Br J Pharmacol 2011;164:584-97. [PMID: 21457229 DOI: 10.1111/j.1476-5381.2011.01400.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 3.7] [Reference Citation Analysis]
77 Gilbert RE, Game DS, Advani A. Vasoactive Molecules and the Kidney. Brenner and Rector's The Kidney 2012. [DOI: 10.1016/b978-1-4160-6193-9.10012-0] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
78 Aggarwal NT, Gauthier KM, Campbell WB. Endothelial nitric oxide and 15-lipoxygenase-1 metabolites independently mediate relaxation of the rabbit aorta. Vascul Pharmacol 2012;56:106-12. [PMID: 22197897 DOI: 10.1016/j.vph.2011.12.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
79 Johnson KR, Hoagland TM, Olson KR. Endogenous vascular synthesis of B-type and C-type natriuretic peptides in the rainbow trout. J Exp Biol 2011;214:2709-17. [PMID: 21795567 DOI: 10.1242/jeb.052415] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
80 Beyer AM, Gutterman DD. Regulation of the human coronary microcirculation. J Mol Cell Cardiol 2012;52:814-21. [PMID: 22033434 DOI: 10.1016/j.yjmcc.2011.10.003] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 3.6] [Reference Citation Analysis]
81 Félétou M, Köhler R, Vanhoutte PM. Nitric oxide: orchestrator of endothelium-dependent responses. Ann Med 2012;44:694-716. [PMID: 21895549 DOI: 10.3109/07853890.2011.585658] [Cited by in Crossref: 114] [Cited by in F6Publishing: 116] [Article Influence: 9.5] [Reference Citation Analysis]
82 Calvieri C, Rubattu S, Volpe M. Molecular mechanisms underlying cardiac antihypertrophic and antifibrotic effects of natriuretic peptides. J Mol Med (Berl) 2012;90:5-13. [PMID: 21826523 DOI: 10.1007/s00109-011-0801-z] [Cited by in Crossref: 50] [Cited by in F6Publishing: 53] [Article Influence: 4.2] [Reference Citation Analysis]
83 Félétou M. The Endothelium, Part I: Multiple Functions of the Endothelial Cells -- Focus on Endothelium-Derived Vasoactive Mediators. Colloquium Series on Integrated Systems Physiology: From Molecule to Function 2011;3:1-306. [DOI: 10.4199/c00031ed1v01y201105isp019] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 3.8] [Reference Citation Analysis]
84 Félétou M. The Endothelium, Part II: EDHF-Mediated Responses "The Classical Pathway". Colloquium Series on Integrated Systems Physiology: From Molecule to Function 2011;3:1-306. [DOI: 10.4199/c00032ed1v01y201105isp020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
85 Nayak L, Lin Z, Jain MK. "Go with the flow": how Krüppel-like factor 2 regulates the vasoprotective effects of shear stress. Antioxid Redox Signal 2011;15:1449-61. [PMID: 20919941 DOI: 10.1089/ars.2010.3647] [Cited by in Crossref: 80] [Cited by in F6Publishing: 85] [Article Influence: 6.7] [Reference Citation Analysis]
86 Morton JS, Rueda-clausen CF, Davidge ST. Flow-mediated vasodilation is impaired in adult rat offspring exposed to prenatal hypoxia. Journal of Applied Physiology 2011;110:1073-82. [DOI: 10.1152/japplphysiol.01174.2010] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 4.2] [Reference Citation Analysis]
87 Villar IC, Scotland RS, Khambata RS, Chan M, Duchene J, Sampaio AL, Perretti M, Hobbs AJ, Ahluwalia A. Suppression of endothelial P-selectin expression contributes to reduced cell trafficking in females: an effect independent of NO and prostacyclin. Arterioscler Thromb Vasc Biol 2011;31:1075-83. [PMID: 21350195 DOI: 10.1161/ATVBAHA.111.223545] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
88 Sangaralingham SJ, Huntley BK, Martin FL, McKie PM, Bellavia D, Ichiki T, Harders GE, Chen HH, Burnett JC. The aging heart, myocardial fibrosis, and its relationship to circulating C-type natriuretic Peptide. Hypertension. 2011;57:201-207. [PMID: 21189408 DOI: 10.1161/hypertensionaha.110.160796] [Cited by in Crossref: 75] [Cited by in F6Publishing: 76] [Article Influence: 5.8] [Reference Citation Analysis]
89 Caniffi C, Elesgaray R, Gironacci M, Arranz C, Costa MÁ. C-type natriuretic peptide effects on cardiovascular nitric oxide system in spontaneously hypertensive rats. Peptides 2010;31:1309-18. [DOI: 10.1016/j.peptides.2010.03.030] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
90 Edwards G, Félétou M, Weston AH. Endothelium-derived hyperpolarising factors and associated pathways: a synopsis. Pflugers Arch. 2010;459:863-879. [PMID: 20383718 DOI: 10.1007/s00424-010-0817-1] [Cited by in Crossref: 266] [Cited by in F6Publishing: 279] [Article Influence: 20.5] [Reference Citation Analysis]
91 Campbell WB, Fleming I. Epoxyeicosatrienoic acids and endothelium-dependent responses. Pflugers Arch 2010;459:881-95. [PMID: 20224870 DOI: 10.1007/s00424-010-0804-6] [Cited by in Crossref: 183] [Cited by in F6Publishing: 182] [Article Influence: 14.1] [Reference Citation Analysis]
92 Rautureau Y, Gowers I, Wheeler-Jones CP, Baxter GF. C-type natriuretic peptide regulation of guanosine-3',5'-cyclic monophosphate production in human endothelial cells. Auton Autacoid Pharmacol 2010;30:185-92. [PMID: 20085572 DOI: 10.1111/j.1474-8673.2009.00449.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
93 Morton JS, Rueda-Clausen CF, Davidge ST. Mechanisms of endothelium-dependent vasodilation in male and female, young and aged offspring born growth restricted. Am J Physiol Regul Integr Comp Physiol 2010;298:R930-8. [PMID: 20053962 DOI: 10.1152/ajpregu.00641.2009] [Cited by in Crossref: 65] [Cited by in F6Publishing: 65] [Article Influence: 5.0] [Reference Citation Analysis]
94 Bahrami S, Pelinka L, Khadem A, Maitzen S, Hawa G, van Griensven M, Redl H. Circulating NT-proCNP predicts sepsis in multiple-traumatized patients without traumatic brain injury*: . Critical Care Medicine 2010;38:161-6. [DOI: 10.1097/ccm.0b013e3181b78a06] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 2.7] [Reference Citation Analysis]
95 Simon A, Liu GX, Koren G, Choudhary G. cANF causes endothelial cell hyperpolarization by activation of chloride channels. Peptides 2009;30:2337-42. [DOI: 10.1016/j.peptides.2009.08.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
96 Savoia C, Volpe M, Alonzo A, Rossi C, Rubattu S. Natriuretic peptides and cardiovascular damage in the metabolic syndrome: molecular mechanisms and clinical implications. Clin Sci (Lond) 2009;118:231-40. [PMID: 19886866 DOI: 10.1042/CS20090204] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 1.7] [Reference Citation Analysis]
97 Félétou M, Vanhoutte PM. EDHF: an update. Clin Sci (Lond). 2009;117:139-155. [PMID: 19601928 DOI: 10.1042/cs20090096] [Cited by in Crossref: 245] [Cited by in F6Publishing: 257] [Article Influence: 17.5] [Reference Citation Analysis]
98 Félétou M, Vanhoutte PM. Endothelium‐dependent hyperpolarizations: Past beliefs and present facts. Annals of Medicine 2009;39:495-516. [DOI: 10.1080/07853890701491000] [Cited by in Crossref: 107] [Cited by in F6Publishing: 94] [Article Influence: 7.6] [Reference Citation Analysis]
99 Chawengsub Y, Gauthier KM, Campbell WB. Role of arachidonic acid lipoxygenase metabolites in the regulation of vascular tone. Am J Physiol Heart Circ Physiol 2009;297:H495-507. [PMID: 19525377 DOI: 10.1152/ajpheart.00349.2009] [Cited by in Crossref: 66] [Cited by in F6Publishing: 73] [Article Influence: 4.7] [Reference Citation Analysis]
100 Figueroa XF, Duling BR. Gap junctions in the control of vascular function. Antioxid Redox Signal 2009;11:251-66. [PMID: 18831678 DOI: 10.1089/ars.2008.2117] [Cited by in Crossref: 201] [Cited by in F6Publishing: 215] [Article Influence: 14.4] [Reference Citation Analysis]
101 Luksha L, Agewall S, Kublickiene K. Endothelium-derived hyperpolarizing factor in vascular physiology and cardiovascular disease. Atherosclerosis 2009;202:330-44. [DOI: 10.1016/j.atherosclerosis.2008.06.008] [Cited by in Crossref: 123] [Cited by in F6Publishing: 132] [Article Influence: 8.8] [Reference Citation Analysis]
102 Kemp-Harper B, Schmidt HH. cGMP in the vasculature. Handb Exp Pharmacol 2009;:447-67. [PMID: 19089340 DOI: 10.1007/978-3-540-68964-5_19] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 2.7] [Reference Citation Analysis]
103 Ng KF, Leung SW, Man RY, Vanhoutte PM. Endothelium-derived hyperpolarizing factor mediated relaxations in pig coronary arteries do not involve Gi/o proteins. Acta Pharmacol Sin 2008;29:1419-24. [PMID: 19026160 DOI: 10.1111/j.1745-7254.2008.00905.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
104 Simon A, Harrington EO, Liu GX, Koren G, Choudhary G. Mechanism of C-type natriuretic peptide-induced endothelial cell hyperpolarization. Am J Physiol Lung Cell Mol Physiol 2009;296:L248-56. [PMID: 19036874 DOI: 10.1152/ajplung.90303.2008] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 1.4] [Reference Citation Analysis]
105 Oltman CL, Davidson EP, Coppey LJ, Kleinschmidt TL, Yorek MA. Treatment of Zucker diabetic fatty rats with AVE7688 improves vascular and neural dysfunction. Diabetes Obes Metab 2009;11:223-33. [PMID: 18564175 DOI: 10.1111/j.1463-1326.2008.00924.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 2.5] [Reference Citation Analysis]
106 Troncoso Brindeiro CM, Fallet RW, Lane PH, Carmines PK. Potassium channel contributions to afferent arteriolar tone in normal and diabetic rat kidney. Am J Physiol Renal Physiol 2008;295:F171-8. [PMID: 18495797 DOI: 10.1152/ajprenal.00563.2007] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
107 Schreier B, Börner S, Völker K, Gambaryan S, Schäfer SC, Kuhlencordt P, Gassner B, Kuhn M. The heart communicates with the endothelium through the guanylyl cyclase-A receptor: acute handling of intravascular volume in response to volume expansion. Endocrinology 2008;149:4193-9. [PMID: 18450968 DOI: 10.1210/en.2008-0212] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 1.6] [Reference Citation Analysis]
108 Kun A, Kiraly I, Pataricza J, Marton Z, Krassoi I, Varro A, Simonsen U, Papp JG, Pajor L. C-Type Natriuretic Peptide Hyperpolarizes and Relaxes Human Penile Resistance Arteries. The Journal of Sexual Medicine 2008;5:1114-25. [DOI: 10.1111/j.1743-6109.2008.00775.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 2.3] [Reference Citation Analysis]
109 Gauthier KM, Yang W, Gross GJ, Campbell WB. Roles of epoxyeicosatrienoic acids in vascular regulation and cardiac preconditioning. J Cardiovasc Pharmacol. 2007;50:601-608. [PMID: 18091575 DOI: 10.1097/FJC.0b013e318159cbe3] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 2.5] [Reference Citation Analysis]
110 Mishra RC, Tripathy S, Desai KM, Quest D, Lu Y, Akhtar J, Gopalakrishnan V. Nitric oxide synthase inhibition promotes endothelium-dependent vasodilatation and the antihypertensive effect of L-serine. Hypertension 2008;51:791-6. [PMID: 18212272 DOI: 10.1161/HYPERTENSIONAHA.107.099598] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]
111 Gauthier KM, Chawengsub Y, Goldman DH, Conrow RE, Anjaiah S, Falck JR, Campbell WB. 11(R),12(S),15(S)-trihydroxyeicosa-5(Z),8(Z),13(E)-trienoic acid: an endothelium-derived 15-lipoxygenase metabolite that relaxes rabbit aorta. Am J Physiol Heart Circ Physiol 2008;294:H1467-72. [PMID: 18203841 DOI: 10.1152/ajpheart.01052.2007] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.2] [Reference Citation Analysis]
112 Chawengsub Y, Aggarwal NT, Nithipatikom K, Gauthier KM, Anjaiah S, Hammock BD, Falck JR, Campbell WB. Identification of 15-hydroxy-11,12-epoxyeicosatrienoic acid as a vasoactive 15-lipoxygenase metabolite in rabbit aorta. Am J Physiol Heart Circ Physiol 2008;294:H1348-56. [PMID: 18192225 DOI: 10.1152/ajpheart.01326.2007] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]
113 Woodard GE, Rosado JA. Natriuretic peptides in vascular physiology and pathology. Int Rev Cell Mol Biol 2008;268:59-93. [PMID: 18703404 DOI: 10.1016/S1937-6448(08)00803-4] [Cited by in Crossref: 84] [Cited by in F6Publishing: 86] [Article Influence: 5.6] [Reference Citation Analysis]
114 Rose RA, Giles WR. Natriuretic peptide C receptor signalling in the heart and vasculature. J Physiol. 2008;586:353-366. [PMID: 18006579 DOI: 10.1113/jphysiol.2007.144253] [Cited by in Crossref: 153] [Cited by in F6Publishing: 155] [Article Influence: 9.6] [Reference Citation Analysis]
115 Park K, Itoh H, Yamahara K, Sone M, Miyashita K, Oyamada N, Sawada N, Taura D, Inuzuka M, Sonoyama T, Tsujimoto H, Fukunaga Y, Tamura N, Nakao K. Therapeutic potential of atrial natriuretic peptide administration on peripheral arterial diseases. Endocrinology 2008;149:483-91. [PMID: 17991722 DOI: 10.1210/en.2007-1094] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 1.4] [Reference Citation Analysis]
116 Garland CJ, Dora KA. Evidence against C-type natriuretic peptide as an arterial 'EDHF'. Br J Pharmacol 2008;153:4-5. [PMID: 17965742 DOI: 10.1038/sj.bjp.0707520] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
117 Moffatt P, Thomas G, Sellin K, Bessette MC, Lafrenière F, Akhouayri O, St-Arnaud R, Lanctôt C. Osteocrin is a specific ligand of the natriuretic Peptide clearance receptor that modulates bone growth. J Biol Chem 2007;282:36454-62. [PMID: 17951249 DOI: 10.1074/jbc.M708596200] [Cited by in Crossref: 63] [Cited by in F6Publishing: 64] [Article Influence: 3.9] [Reference Citation Analysis]
118 Leuranguer V, Vanhoutte PM, Verbeuren T, Félétou M. C-type natriuretic peptide and endothelium-dependent hyperpolarization in the guinea-pig carotid artery. Br J Pharmacol 2008;153:57-65. [PMID: 17906681 DOI: 10.1038/sj.bjp.0707476] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 1.6] [Reference Citation Analysis]
119 Atkins GB, Jain MK. Role of Krüppel-Like Transcription Factors in Endothelial Biology. Circulation Research 2007;100:1686-95. [DOI: 10.1161/01.res.0000267856.00713.0a] [Cited by in Crossref: 292] [Cited by in F6Publishing: 301] [Article Influence: 18.3] [Reference Citation Analysis]
120 Harrington LS, Carrier MJ, Gallagher N, Gilroy D, Garland CJ, Mitchell JA. Elucidation of the temporal relationship between endothelial-derived NO and EDHF in mesenteric vessels. Am J Physiol Heart Circ Physiol 2007;293:H1682-8. [PMID: 17557917 DOI: 10.1152/ajpheart.00389.2007] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]
121 Costa MA, Elesgaray R, Caniffi C, Fellet A, Arranz C. Role of cardiovascular nitric oxide system in C-type natriuretic peptide effects. Biochem Biophys Res Commun 2007;359:180-6. [PMID: 17532295 DOI: 10.1016/j.bbrc.2007.05.095] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
122 Morio Y, Homma N, Takahashi H, Yamamoto A, Nagaoka T, Sato K, Muramatsu M, Fukuchi Y. Activity of endothelium-derived hyperpolarizing factor is augmented in monocrotaline-induced pulmonary hypertension of rat lungs. J Vasc Res 2007;44:325-35. [PMID: 17438361 DOI: 10.1159/000101778] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
123 Pagel-langenickel I, Buttgereit J, Bader M, Langenickel TH. Natriuretic peptide receptor B signaling in the cardiovascular system: protection from cardiac hypertrophy. J Mol Med 2007;85:797-810. [DOI: 10.1007/s00109-007-0183-4] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 2.1] [Reference Citation Analysis]
124 Sokoya EM, Burns AR, Marrelli SP, Chen J. Myoendothelial gap junction frequency does not account for sex differences in EDHF responses in rat MCA. Microvasc Res 2007;74:39-44. [PMID: 17490692 DOI: 10.1016/j.mvr.2007.03.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
125 Wang Y, de Waard MC, Sterner-Kock A, Stepan H, Schultheiss HP, Duncker DJ, Walther T. Cardiomyocyte-restricted over-expression of C-type natriuretic peptide prevents cardiac hypertrophy induced by myocardial infarction in mice. Eur J Heart Fail 2007;9:548-57. [PMID: 17407830 DOI: 10.1016/j.ejheart.2007.02.006] [Cited by in Crossref: 72] [Cited by in F6Publishing: 73] [Article Influence: 4.5] [Reference Citation Analysis]
126 Villar IC, Panayiotou CM, Sheraz A, Madhani M, Scotland RS, Nobles M, Kemp-Harper B, Ahluwalia A, Hobbs AJ. Definitive role for natriuretic peptide receptor-C in mediating the vasorelaxant activity of C-type natriuretic peptide and endothelium-derived hyperpolarising factor. Cardiovasc Res 2007;74:515-25. [PMID: 17391657 DOI: 10.1016/j.cardiores.2007.02.032] [Cited by in Crossref: 70] [Cited by in F6Publishing: 70] [Article Influence: 4.4] [Reference Citation Analysis]
127 Sandow SL, Tare M. C-type natriuretic peptide: a new endothelium-derived hyperpolarizing factor? Trends in Pharmacological Sciences 2007;28:61-7. [DOI: 10.1016/j.tips.2006.12.007] [Cited by in Crossref: 53] [Cited by in F6Publishing: 54] [Article Influence: 3.3] [Reference Citation Analysis]
128 Garcha RS, Hughes AD. CNP, but not ANP or BNP, relax human isolated subcutaneous resistance arteries by an action involving cyclic GMP and BKCa channels. J Renin Angiotensin Aldosterone Syst 2006;7:87-91. [PMID: 17083062 DOI: 10.3317/jraas.2006.014] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
129 Nakazawa T, Kaneko Y, Mori A, Saito M, Sakamoto K, Nakahara T, Ishii K. Attenuation of nitric oxide- and prostaglandin-independent vasodilation of retinal arterioles induced by acetylcholine in streptozotocin-treated rats. Vascul Pharmacol 2007;46:153-9. [PMID: 17079193 DOI: 10.1016/j.vph.2006.09.002] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 2.5] [Reference Citation Analysis]
130 Pannirselvam M, Ding H, Anderson TJ, Triggle CR. Pharmacological characteristics of endothelium-derived hyperpolarizing factor-mediated relaxation of small mesenteric arteries from db/db mice. Eur J Pharmacol 2006;551:98-107. [PMID: 17027963 DOI: 10.1016/j.ejphar.2006.08.086] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 2.4] [Reference Citation Analysis]
131 Stankevicius E, Lopez-Valverde V, Rivera L, Hughes AD, Mulvany MJ, Simonsen U. Combination of Ca2+ -activated K+ channel blockers inhibits acetylcholine-evoked nitric oxide release in rat superior mesenteric artery. Br J Pharmacol 2006;149:560-72. [PMID: 16967048 DOI: 10.1038/sj.bjp.0706886] [Cited by in Crossref: 61] [Cited by in F6Publishing: 63] [Article Influence: 3.6] [Reference Citation Analysis]
132 Mendonça MC, Doi SQ, Glerum S, Sellitti DF. Increase of C-Type Natriuretic Peptide Expression by Serum and Platelet-Derived Growth Factor-BB in Human Aortic Smooth Muscle Cells Is Dependent on Protein Kinase C Activation. Endocrinology 2006;147:4169-78. [DOI: 10.1210/en.2006-0239] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
133 Lakshminrusimha S, Russell JA, Gugino SF, Ryan RM, Mathew B, Nielsen LC, Morin FC. Adjacent bronchus attenuates pulmonary arterial contractility. American Journal of Physiology-Lung Cellular and Molecular Physiology 2006;291:L473-8. [DOI: 10.1152/ajplung.00313.2005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
134 Villar I, Francis S, Webb A, Hobbs A, Ahluwalia A. Novel aspects of endothelium-dependent regulation of vascular tone. Kidney International 2006;70:840-53. [DOI: 10.1038/sj.ki.5001680] [Cited by in Crossref: 80] [Cited by in F6Publishing: 81] [Article Influence: 4.7] [Reference Citation Analysis]
135 Moro C, Berlan M. Cardiovascular and metabolic effects of natriuretic peptides. Fundam Clin Pharmacol 2006;20:41-9. [PMID: 16448393 DOI: 10.1111/j.1472-8206.2005.00379.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
136 Del Ry S, Passino C, Emdin M, Giannessi D. C-type natriuretic peptide and heart failure. Pharmacol Res 2006;54:326-33. [PMID: 16904335 DOI: 10.1016/j.phrs.2006.06.011] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
137 Danser AH, Saris JJ. 77th Scientific Sessions of the American Heart Association. Expert Opin Investig Drugs 2005;14:203-7. [PMID: 15757397 DOI: 10.1517/13543784.14.2.203] [Reference Citation Analysis]
138 Félétou M, Vanhoutte PM. Endothelium-derived hyperpolarizing factor: where are we now? Arterioscler Thromb Vasc Biol. 2006;26:1215-1225. [PMID: 16543495 DOI: 10.1161/01.atv.0000217611.81085.c5] [Cited by in Crossref: 357] [Cited by in F6Publishing: 371] [Article Influence: 21.0] [Reference Citation Analysis]
139 Lin CS, Lin G, Lue TF. Cyclic nucleotide signaling in cavernous smooth muscle. J Sex Med 2005;2:478-91. [PMID: 16422842 DOI: 10.1111/j.1743-6109.2005.00080.x] [Cited by in Crossref: 59] [Cited by in F6Publishing: 63] [Article Influence: 3.5] [Reference Citation Analysis]
140 Potter LR, Abbey-Hosch S, Dickey DM. Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. Endocr Rev 2006;27:47-72. [PMID: 16291870 DOI: 10.1210/er.2005-0014] [Cited by in Crossref: 740] [Cited by in F6Publishing: 767] [Article Influence: 41.1] [Reference Citation Analysis]
141 References. EDHF 2005. [DOI: 10.1201/9781420023312.bmatt] [Reference Citation Analysis]
142 Siegl D, Koeppen M, Wölfle SE, Pohl U, de Wit C. Myoendothelial Coupling Is Not Prominent in Arterioles Within the Mouse Cremaster Microcirculation In Vivo. Circulation Research 2005;97:781-8. [DOI: 10.1161/01.res.0000186193.22438.6c] [Cited by in Crossref: 68] [Cited by in F6Publishing: 73] [Article Influence: 3.8] [Reference Citation Analysis]
143 Márton Z, Pataricza J, Krassói I, Varró A, Papp JG. NEP inhibitors enhance C-type natriuretic peptide-induced relaxation in porcine isolated coronary artery. Vascular Pharmacology 2005;43:207-12. [DOI: 10.1016/j.vph.2005.07.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
144 Scotland RS, Cohen M, Foster P, Lovell M, Mathur A, Ahluwalia A, Hobbs AJ. C-type natriuretic peptide inhibits leukocyte recruitment and platelet-leukocyte interactions via suppression of P-selectin expression. Proc Natl Acad Sci U S A 2005;102:14452-7. [PMID: 16179391 DOI: 10.1073/pnas.0504961102] [Cited by in Crossref: 70] [Cited by in F6Publishing: 73] [Article Influence: 3.9] [Reference Citation Analysis]
145 O'Sullivan SE, Kendall DA, Randall MD. The effects of Delta9-tetrahydrocannabinol in rat mesenteric vasculature, and its interactions with the endocannabinoid anandamide. Br J Pharmacol 2005;145:514-26. [PMID: 15821751 DOI: 10.1038/sj.bjp.0706218] [Cited by in Crossref: 35] [Cited by in F6Publishing: 39] [Article Influence: 1.9] [Reference Citation Analysis]
146 Jackson WF. Potassium channels in the peripheral microcirculation. Microcirculation 2005;12:113-27. [PMID: 15804979 DOI: 10.1080/10739680590896072] [Cited by in Crossref: 249] [Cited by in F6Publishing: 225] [Article Influence: 13.8] [Reference Citation Analysis]
147 McGuire JJ, Hollenberg MD, Bennett BM, Triggle CR. Hyperpolarization of murine small caliber mesenteric arteries by activation of endothelial proteinase-activated receptor 2. Can J Physiol Pharmacol 2004;82:1103-12. [PMID: 15644953 DOI: 10.1139/y04-121] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 1.5] [Reference Citation Analysis]
148 Parmar KM, Nambudiri V, Dai G, Larman HB, Gimbrone MA, García-cardeña G. Statins Exert Endothelial Atheroprotective Effects via the KLF2 Transcription Factor. Journal of Biological Chemistry 2005;280:26714-9. [DOI: 10.1074/jbc.c500144200] [Cited by in Crossref: 175] [Cited by in F6Publishing: 186] [Article Influence: 9.7] [Reference Citation Analysis]
149 Fitzgerald SM, Kemp-harper BK, Tare M, Parkington HC. ROLE OF ENDOTHELIUM-DERIVED HYPERPOLARIZING FACTOR IN ENDOTHELIAL DYSFUNCTION DURING DIABETES. Clin Exp Pharmacol Physiol 2005;32:482-7. [DOI: 10.1111/j.1440-1681.2005.04216.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 2.2] [Reference Citation Analysis]
150 Griffith TM. Endothelium-dependent smooth muscle hyperpolarization: do gap junctions provide a unifying hypothesis? Br J Pharmacol 2004;141:881-903. [PMID: 15028638 DOI: 10.1038/sj.bjp.0705698] [Cited by in Crossref: 183] [Cited by in F6Publishing: 190] [Article Influence: 10.2] [Reference Citation Analysis]
151 Ortega J, Vila JM, Mauricio MD, Segarra G, Medina P, Martínez-león JB, Lluch S. Nitric oxide mediates abnormal responsiveness of thyroid arteries in methimazole-treated patients. eur j endocrinol 2005;152:551-6. [DOI: 10.1530/eje.1.01889] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
152 Gauthier KM, Edwards EM, Falck JR, Reddy DS, Campbell WB. 14,15-Epoxyeicosatrienoic Acid Represents a Transferable Endothelium-Dependent Relaxing Factor in Bovine Coronary Arteries. Hypertension 2005;45:666-71. [DOI: 10.1161/01.hyp.0000153462.06604.5d] [Cited by in Crossref: 61] [Cited by in F6Publishing: 63] [Article Influence: 3.4] [Reference Citation Analysis]
153 . EDHF(<特集I>基礎科学の進歩). Journal of JCS Cardiologists 2005;13:3-7. [DOI: 10.1253/jjcsc.13.1_3] [Reference Citation Analysis]
154 Chauhan SD, Hobbs AJ, Ahluwalia A. C-type natriuretic peptide: new candidate for endothelium-derived hyperpolarising factor. Int J Biochem Cell Biol 2004;36:1878-81. [PMID: 15203101 DOI: 10.1016/j.biocel.2003.09.009] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.2] [Reference Citation Analysis]
155 Naruko T, Itoh A, Haze K, Ehara S, Fukushima H, Sugama Y, Shirai N, Ikura Y, Ohsawa M, Ueda M. C-Type natriuretic peptide and natriuretic peptide receptors are expressed by smooth muscle cells in the neointima after percutaneous coronary intervention. Atherosclerosis 2005;181:241-50. [PMID: 16039277 DOI: 10.1016/j.atherosclerosis.2005.01.023] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 1.7] [Reference Citation Analysis]
156 Venugopal J. Pharmacological modulation of the natriuretic peptide system. Expert Opinion on Therapeutic Patents 2005;13:1389-409. [DOI: 10.1517/13543776.13.9.1389] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
157 Ahluwalia A, Hobbs AJ. Endothelium-derived C-type natriuretic peptide: more than just a hyperpolarizing factor. Trends in Pharmacological Sciences 2005;26:162-7. [DOI: 10.1016/j.tips.2005.01.005] [Cited by in Crossref: 56] [Cited by in F6Publishing: 56] [Article Influence: 3.1] [Reference Citation Analysis]
158 Sandow SL. Factors, fiction and endothelium-derived hyperpolarizing factor. Clin Exp Pharmacol Physiol 2004;31:563-70. [PMID: 15479161 DOI: 10.1111/j.1440-1681.2004.04048.x] [Cited by in Crossref: 84] [Cited by in F6Publishing: 86] [Article Influence: 4.7] [Reference Citation Analysis]
159 Scotland RS, Madhani M, Chauhan S, Moncada S, Andresen J, Nilsson H, Hobbs AJ, Ahluwalia A. Investigation of vascular responses in endothelial nitric oxide synthase/cyclooxygenase-1 double-knockout mice: key role for endothelium-derived hyperpolarizing factor in the regulation of blood pressure in vivo. Circulation. 2005;111:796-803. [PMID: 15699263 DOI: 10.1161/01.cir.0000155238.70797.4e] [Cited by in Crossref: 163] [Cited by in F6Publishing: 169] [Article Influence: 9.1] [Reference Citation Analysis]
160 Scotland RS, Ahluwalia A, Hobbs AJ. C-type natriuretic peptide in vascular physiology and disease. Pharmacology & Therapeutics 2005;105:85-93. [DOI: 10.1016/j.pharmthera.2004.08.011] [Cited by in Crossref: 92] [Cited by in F6Publishing: 96] [Article Influence: 5.1] [Reference Citation Analysis]
161 Puggina E, Sellitti D. Cyclic adenosine monophosphate (cAMP) increases natriuretic peptide receptor C (NPR-C) expression in human aortic smooth muscle cells. Mol Cell Endocrinol 2004;219:161-9. [PMID: 15149737 DOI: 10.1016/j.mce.2003.12.015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
162 Heimeier RA, Donald JA. Renal C-type natriuretic peptide and natriuretic peptide receptor B mRNA expression are affected by water deprivation in the Spinifex Hopping mouse. Comp Biochem Physiol A Mol Integr Physiol 2003;136:565-75. [PMID: 14613785 DOI: 10.1016/s1095-6433(03)00207-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
163 Schmitt M, Qasem A, Mceniery C, Wilkinson IB, Tatarinoff V, Noble K, Klemes J, Payne N, Frenneaux MP, Cockcroft J, Avolio A. Role of natriuretic peptides in regulation of conduit artery distensibility. American Journal of Physiology-Heart and Circulatory Physiology 2004;287:H1167-71. [DOI: 10.1152/ajpheart.00101.2004] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 1.3] [Reference Citation Analysis]
164 Hobbs A, Foster P, Prescott C, Scotland R, Ahluwalia A. Natriuretic peptide receptor-C regulates coronary blood flow and prevents myocardial ischemia/reperfusion injury: novel cardioprotective role for endothelium-derived C-type natriuretic peptide. Circulation 2004;110:1231-5. [PMID: 15337698 DOI: 10.1161/01.CIR.0000141802.29945.34] [Cited by in Crossref: 101] [Cited by in F6Publishing: 104] [Article Influence: 5.3] [Reference Citation Analysis]
165 D'Souza SP, Davis M, Baxter GF. Autocrine and paracrine actions of natriuretic peptides in the heart. Pharmacol Ther 2004;101:113-29. [PMID: 14761702 DOI: 10.1016/j.pharmthera.2003.11.001] [Cited by in Crossref: 154] [Cited by in F6Publishing: 141] [Article Influence: 8.1] [Reference Citation Analysis]
166 Itaba S, Chijiiwa Y, Matsuzaka H, Motomura Y, Nawata H. Presence of C-type natriuretic peptide (CNP) in guinea pig caecum: role and mechanisms of CNP in circular smooth muscle relaxation. Neurogastroenterol Motil 2004;16:375-82. [PMID: 15198660 DOI: 10.1111/j.1365-2982.2004.00506.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 0.8] [Reference Citation Analysis]
167 Crane GJ, Garland CJ. Thromboxane receptor stimulation associated with loss of SKCa activity and reduced EDHF responses in the rat isolated mesenteric artery. Br J Pharmacol 2004;142:43-50. [PMID: 15051624 DOI: 10.1038/sj.bjp.0705756] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 2.2] [Reference Citation Analysis]
168 Sandow SL, Goto K, Rummery NM, Hill CE. Developmental changes in myoendothelial gap junction mediated vasodilator activity in the rat saphenous artery. J Physiol 2004;556:875-86. [PMID: 14766938 DOI: 10.1113/jphysiol.2003.058669] [Cited by in Crossref: 57] [Cited by in F6Publishing: 60] [Article Influence: 3.0] [Reference Citation Analysis]
169 Breyne J, Vanheel BJ. Role of Ba 2+ -resistant K + channels in endothelium-dependent hyperpolarization of rat small mesenteric arteries. Can J Physiol Pharmacol 2004;82:65-71. [DOI: 10.1139/y03-132] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
170 Lin C, Lue TF. Cyclic nucleotide signaling in vascular and cavernous smooth muscle: aging-related changes. Protien Phosphorylation in Aging and Age-related Disease. Elsevier; 2004. pp. 57-106. [DOI: 10.1016/s1566-3124(04)16004-5] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
171 Donald JA, Broughton BR, Bennett MB. Vasodilator mechanisms in the dorsal aorta of the giant shovelnose ray, Rhinobatus typus (Rajiformes; Rhinobatidae). Comparative Biochemistry and Physiology Part A: Molecular & Integrative Physiology 2004;137:21-31. [DOI: 10.1016/s1095-6433(03)00260-5] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.2] [Reference Citation Analysis]
172 Wollert KC, Yurukova S, Kilic A, Begrow F, Fiedler B, Gambaryan S, Walter U, Lohmann SM, Kuhn M. Increased effects of C-type natriuretic peptide on contractility and calcium regulation in murine hearts overexpressing cyclic GMP-dependent protein kinase I. Br J Pharmacol 2003;140:1227-36. [PMID: 14609817 DOI: 10.1038/sj.bjp.0705567] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 2.2] [Reference Citation Analysis]
173 Martinez-le??n JB, Segarra G, Medina P, Vila JM, Lluch P, Peir?? M, Otero E, Lluch S. Ca2+-activated K+ channels mediate relaxation of forearm veins in chronic renal failure: . Journal of Hypertension 2003;21:1927-34. [DOI: 10.1097/00004872-200310000-00021] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 0.9] [Reference Citation Analysis]
174 Rose RA, Lomax AE, Giles WR. Inhibition of L-type Ca2+ current by C-type natriuretic peptide in bullfrog atrial myocytes: an NPR-C-mediated effect. Am J Physiol Heart Circ Physiol 2003;285:H2454-62. [PMID: 12881210 DOI: 10.1152/ajpheart.00388.2003] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 1.3] [Reference Citation Analysis]